1. Home
  2. PMEC vs GRCE Comparison

PMEC vs GRCE Comparison

Compare PMEC & GRCE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PMEC
  • GRCE
  • Stock Information
  • Founded
  • PMEC 1984
  • GRCE 2002
  • Country
  • PMEC Singapore
  • GRCE United States
  • Employees
  • PMEC N/A
  • GRCE N/A
  • Industry
  • PMEC
  • GRCE
  • Sector
  • PMEC
  • GRCE
  • Exchange
  • PMEC Nasdaq
  • GRCE NYSE
  • Market Cap
  • PMEC 26.1M
  • GRCE 30.9M
  • IPO Year
  • PMEC 2023
  • GRCE N/A
  • Fundamental
  • Price
  • PMEC $0.75
  • GRCE $3.78
  • Analyst Decision
  • PMEC
  • GRCE
  • Analyst Count
  • PMEC 0
  • GRCE 0
  • Target Price
  • PMEC N/A
  • GRCE N/A
  • AVG Volume (30 Days)
  • PMEC 71.5K
  • GRCE 74.2K
  • Earning Date
  • PMEC 12-31-2024
  • GRCE 12-24-2024
  • Dividend Yield
  • PMEC N/A
  • GRCE N/A
  • EPS Growth
  • PMEC N/A
  • GRCE N/A
  • EPS
  • PMEC N/A
  • GRCE N/A
  • Revenue
  • PMEC $72,524,000.00
  • GRCE N/A
  • Revenue This Year
  • PMEC N/A
  • GRCE N/A
  • Revenue Next Year
  • PMEC N/A
  • GRCE N/A
  • P/E Ratio
  • PMEC N/A
  • GRCE N/A
  • Revenue Growth
  • PMEC 5.07
  • GRCE N/A
  • 52 Week Low
  • PMEC $0.49
  • GRCE $1.98
  • 52 Week High
  • PMEC $4.15
  • GRCE $4.97
  • Technical
  • Relative Strength Index (RSI)
  • PMEC 50.76
  • GRCE N/A
  • Support Level
  • PMEC $0.65
  • GRCE N/A
  • Resistance Level
  • PMEC $0.79
  • GRCE N/A
  • Average True Range (ATR)
  • PMEC 0.07
  • GRCE 0.00
  • MACD
  • PMEC -0.01
  • GRCE 0.00
  • Stochastic Oscillator
  • PMEC 43.78
  • GRCE 0.00

About PMEC Primech Holdings Ltd.

Primech Holdings Ltd is a technology-driven facilities services provider in the public and private sectors operating mainly in Singapore. The services offered by the company include Facilities services, Stewarding services, Cleaning services to offices, Cleaning services to homes, and Cleaning Supplies.

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

Share on Social Networks: